Iran Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Iran Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: We continue to view Iran as a difficult pharmaceutical market. International trade sanctions will continue to have a detrimental impact on the government’s revenues, while shortages of medicines are likely to persist. Additionally, runaway inflation will severely erode US dollar values of the country’s pharmaceutical market, making it even more unattractive to multinational players, despite the large unmet demand for medicines. In the meantime, despite reports of further development of local pharmaceutical manufacturing capabilities and the focus on research into biosimilars, we do not envisage Iran meeting self-sufficiency in this regard, for the foreseeable future. Headline Expenditure Projections … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103180. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/iran-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions